Previous 10 | Next 10 |
GlobeNewswire news releases related Globenewswire news releases and Globenewswire press releases from 11/13/19 04:10:00 on US and Canada Markets.
FOR IMMEDIATE RELEASE Affimed Announces Closing of Public Offering of Common Shares and Exercise of Underwriters’ Option to Purchase Additional Shares Heidelberg, Germany, November 13, 2019 – Affimed N.V. (“Affimed” or the “Company”) (...
UNIONDALE, N.Y., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), today announced the closing of a $635 million commercial real estate mortgage securitization (the “Securitization”). An aggregate of approximately $534 million of investment grade-rated no...
Highlights GAAP net loss attributable to shareholders of Teekay of $198.2 million, or $1.97 per share (inclusive of $175.8 million of impairment charges), and adjusted net loss attributable to shareholders of Teekay (1) of $24.1 million, or $0.24 per share (excluding items listed in ...
Highlights GAAP net income attributable to the partners and preferred unitholders of $47.4 million and GAAP net income per common unit of $0.51. Adjusted net income (1) attributable to the partners and preferred unitholders of $50.5 million and adjusted net income per common unit of $...
Highlights GAAP net loss attributable to shareholders of Teekay of $198.2 million, or $1.97 per share (inclusive of $175.8 million of impairment charges), and adjusted net loss attributable to shareholders of Teekay (1) of $24.1 million, or $0.24 per share (excluding items listed in ...
Highlights GAAP net loss attributable to shareholders of Teekay of $198.2 million, or $1.97 per share (inclusive of $175.8 million of impairment charges), and adjusted net loss attributable to shareholders of Teekay (1) of $24.1 million, or $0.24 per share (excluding items listed in ...
ALPHARETTA, Ga., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that Management will ...
– Investigator-Reported Partial Response in Phase 1 Study of CYC065 as Single Agent – – Conference Call Scheduled November 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, ...
– Investigator-Reported Partial Response in Phase 1 Study of CYC065 as Single Agent – – Conference Call Scheduled November 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, ...
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will participate in the 31st...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.49%Change Percent:
SuperCom Ltd. Company Name:
SPCB Stock Symbol:
NASDAQ Market: